Researchers at Washington University have demonstrated that early life exposure to multiple viruses in house mice dampens the immune response to SARS-CoV-2 vaccinations later in life. The study raises concerns about the applicability of common mouse models in immunological research, suggesting that prior pathogen exposure could be a significant variable in predicting vaccine efficacy.
Mainz Biomed and Bantleon Partner to Elevate Corporate Health with Second Phase of CRC Screening Program for Employees – Biotech Investments
Issuer: Mainz BioMed N.V. / Key word(s): Miscellaneous 19.12.2023 / 14:01 CET/CEST The issuer is solely responsible for the content of this announcement. Mainz Biomed